• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧细胞放射增敏剂研发中的构效关系。I. 增敏效率

Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.

作者信息

Adams G E, Clarke E D, Flockhart I R, Jacobs R S, Sehmi D S, Stratford I J, Wardman P, Watts M E, Parrick J, Wallace R G, Smithen C E

出版信息

Int J Radiat Biol Relat Stud Phys Chem Med. 1979 Feb;35(2):133-50. doi: 10.1080/09553007914550151.

DOI:10.1080/09553007914550151
PMID:312783
Abstract

The efficiency of 35 nitroaromatic and nitroheterocyclic compounds in radiosensitizing hypoxic Chinese Hamster cells in vitro was determined. The concentration C of the compound required to achieve an enhancement ratio of 1.6 was measured, and the redox and partition properties were quantified as the one-electron reduction potential at pH 7, E, and the octanol: water partition coefficient, P, respectively. Most of the compounds studied were 2-nitroimidazoles, but some 4- and 5-nitromidazoles, 5-nitrofurans and nitrobenzenes were investigated for comparison. Together with data for nine nitroimidazoles previously reported, the results were fitted to a structure-activity relationship of the form -log C = b0 + b1E + b2 log P + b3 (log P)2 using multiple linear regression analysis. Statistical tests showed that the coefficients b2 and b3 were not significantly different from zero and the simpler equation, obtained by omitting the terms in log P, explained 85 per cent of the variance in log C. Earlier reports that the radiosensitization efficiency of nitro compounds in vitro largely depends on the reduction potential were confirmed. The conclusive demonstration that P is unimportant in vitro is valuable in interpreting the results of experiments in vivo, where P is expected to have a much greater influence on biological response.

摘要

测定了35种硝基芳香族和硝基杂环化合物在体外对缺氧中国仓鼠细胞的放射增敏效率。测量了达到1.6的增强比所需的化合物浓度C,并分别将氧化还原和分配特性量化为pH 7时的单电子还原电位E和辛醇-水分配系数P。所研究的化合物大多为2-硝基咪唑,但也研究了一些4-和5-硝基咪唑、5-硝基呋喃和硝基苯用于比较。连同先前报道的9种硝基咪唑的数据,使用多元线性回归分析将结果拟合为-log C = b0 + b1E + b2 log P + b3 (log P)2形式的构效关系。统计检验表明,系数b2和b3与零无显著差异,通过省略log P项得到的更简单方程解释了log C中85%的方差。早期关于硝基化合物体外放射增敏效率很大程度上取决于还原电位的报道得到了证实。P在体外不重要这一结论性证明对于解释体内实验结果很有价值,在体内实验中预计P对生物学反应有更大影响。

相似文献

1
Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency.缺氧细胞放射增敏剂研发中的构效关系。I. 增敏效率
Int J Radiat Biol Relat Stud Phys Chem Med. 1979 Feb;35(2):133-50. doi: 10.1080/09553007914550151.
2
Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio.乏氧细胞放射增敏剂研发中的构效关系。II. 细胞毒性与治疗比率。
Int J Radiat Biol Relat Stud Phys Chem Med. 1979 Feb;35(2):151-60. doi: 10.1080/09553007914550161.
3
Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.体外亲电子化合物异常放射增敏行为的一些例子。
Br J Cancer Suppl. 1978 Jun;3:80-3.
4
Abnormal radiosensitizing and cytotoxic properties of ortho-substituted nitroimidazoles.邻位取代硝基咪唑的异常放射增敏和细胞毒性特性。
Int J Radiat Biol Relat Stud Phys Chem Med. 1983 Jan;43(1):31-43. doi: 10.1080/09553008314550031.
5
The use of nitroaromatic compounds as hypoxic cell radiosensitizers.硝基芳香化合物作为低氧细胞放射增敏剂的应用。
Curr Top Radiat Res Q. 1977 Aug;11(4):347-98.
6
Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells.硝基杂环药物作为缺氧哺乳动物细胞的选择性放射增敏剂。
Cancer Chemother Rep. 1974 Jul-Aug;58(4):559-70.
7
The nitroimidazoles as radiosensitizers and cytotoxic agents.作为放射增敏剂和细胞毒剂的硝基咪唑类药物。
Br J Cancer Suppl. 1978 Jun;3:120-3.
8
Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains.
Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Dec;38(6):613-26. doi: 10.1080/09553008014551451.
9
Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA 100 and TA98.使用鼠伤寒沙门氏菌TA 100和TA98菌株筛选含硝基的乏氧细胞放射增敏剂的诱变性。
Mutat Res. 1978 Sep;58(1):1-10.
10
Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.潜在的放射增敏剂。7. 4(5)-碘-5(4)-硝基咪唑衍生物。
J Med Chem. 1985 Aug;28(8):987-91. doi: 10.1021/jm00146a003.

引用本文的文献

1
Low-Energy Electron-Induced Dissociation of the Radiosensitizing Agent Sanazole.低能电子诱导的放射增敏剂沙那唑的解离
Chempluschem. 2025 Jul;90(7):e202500120. doi: 10.1002/cplu.202500120. Epub 2025 May 8.
2
An Analysis of the Radiosensitiser Applications in the Biomedical Field.生物医学领域中放射增敏剂的应用分析
Curr Radiopharm. 2025;18(2):81-99. doi: 10.2174/0118744710269842240825160247.
3
Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.设计、合成及硝基咪唑类放射增敏剂的抗癌评估。
Molecules. 2023 May 31;28(11):4457. doi: 10.3390/molecules28114457.
4
Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study.烯醇化酶的可生物还原磷酰胺前药抑制剂:概念验证研究
ACS Med Chem Lett. 2020 Jun 22;11(7):1484-1489. doi: 10.1021/acsmedchemlett.0c00203. eCollection 2020 Jul 9.
5
Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.硝基咪唑类药物作为乏氧细胞放射增敏剂和乏氧探针:米托唑胺、神话与错误。
Br J Radiol. 2019 Jan;92(1093):20170915. doi: 10.1259/bjr.20170915. Epub 2018 Mar 20.
6
Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia.设计用于靶向肿瘤缺氧的非那他汀生物还原可激活前药缀合物。
Bioorg Med Chem Lett. 2017 Feb 1;27(3):636-641. doi: 10.1016/j.bmcl.2016.11.093. Epub 2016 Dec 1.
7
Synthesis and characterization of a hypoxia-sensitive MRI probe.缺氧敏感性 MRI 探针的合成与表征。
Chemistry. 2012 Jul 27;18(31):9669-76. doi: 10.1002/chem.201200266. Epub 2012 Jun 27.
8
In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography.[18F]氟乙硝唑作为正电子发射断层显像肿瘤缺氧新标志物的体内评价
Br J Cancer. 2004 Jun 1;90(11):2232-42. doi: 10.1038/sj.bjc.6601862.
9
A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.一种新型的缺氧依赖性2-硝基咪唑KIN-841通过阻断血管生成因子的产生来抑制肿瘤特异性血管生成。
Br J Cancer. 2003 Jan 27;88(2):307-13. doi: 10.1038/sj.bjc.6600667.
10
Nitroimidazoles for imaging hypoxic myocardium.
J Nucl Cardiol. 1995 Sep-Oct;2(5):437-45. doi: 10.1016/s1071-3581(05)80031-5.